Lucy Lu

CIK: 0001542419

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VERU

VERU INC.

Director

FBIO

Fortress Biotech, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

VERU
VERU INC.
May 4, 2026
Award(A)
Common Stock Option
Direct
104K shares-
VERU
VERU INC.
Dec 5, 2025
Award(A)
Common Stock Option
Direct
4K shares-
VERU
VERU INC.
Oct 1, 2025
Award(A)
Common Stock Option
Direct
6K shares-
VERU
VERU INC.
May 6, 2025
Award(A)
Common Stock Option
Direct
30K shares-
FBIO
Fortress Biotech, Inc.
Jan 1, 2025
Award(A)
Direct
49.4K shares-
VERU
VERU INC.
Oct 1, 2024
Award(A)
Common Stock Option
Direct
70K shares-

		Type	Shares	Price		Ownership
May 4, 2026	VERU VERU INC.	Award(A) Common Stock Option	104,000	-	-	Direct
Dec 5, 2025	VERU VERU INC.	Award(A) Common Stock Option	4,000	-	-	Direct
Oct 1, 2025	VERU VERU INC.	Award(A) Common Stock Option	6,000	-	-	Direct
May 6, 2025	VERU VERU INC.	Award(A) Common Stock Option	30,000	-	-	Direct
Jan 1, 2025	FBIO Fortress Biotech, Inc.	Award(A)	49,383	-	$0	Direct
Oct 1, 2024	VERU VERU INC.	Award(A) Common Stock Option	70,000	-	-	Direct

1-6 of 6 transactions

About Lu Lucy

Lu Lucy (SEC CIK 0001542419) files insider reports with the SEC as Director of VERU INC. (VERU) and Director of Fortress Biotech, Inc. (FBIO).

Signal8 holds 6 ownership filings by Lu Lucy, all Form 4s, filed between Oct 2, 2024 and May 6, 2026. Those filings report 6 transactions, from Oct 1, 2024 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lu Lucy's filings is in BAY HARBOR ISLANDS, FL.

Recent filings by Lu Lucy

May 4, 2026: Grant or award of VERU derivative securities (Form 4, code A).
Dec 5, 2025: Grant or award of VERU derivative securities (Form 4, code A).
Oct 1, 2025: Grant or award of VERU derivative securities (Form 4, code A).
May 6, 2025: Grant or award of VERU derivative securities (Form 4, code A).
Jan 1, 2025: Grant or award of FBIO shares (Form 4, code A).

Other insiders filing for VERU INC. (VERU)

BARNETTE K GARY, Chief Scientific Officer
STEINER MITCHELL SHUSTER, President and CEO
Greco Michele, Chief Admin Officer and CFO
Katzovitz Loren Mark, Director
Hyun Grace, Director
Rankowitz Michael L, Director

How to read Form 4 transaction codes